Product

Olmesartan + Hydrochlorothiazide

Aliases

Benicar HCT, Benicar HCT®, Olmesartan 20mg + hydrochlorothiazide 12,5mg, Olmesartan 40mg + Hydrochlorothiazide 12,5mg, Olmesartan 40mg + Hydrochlorothiazide 25mg

Name

Benicar Hct

INN Name

olmesartan medoxomil-hydrochlorothiazide

FDA Approved

Yes

2 clinical trials

2 organizations

2 indications

1 document

Indication

Essential hypertension

Indication

Hypertension

Clinical trial

Efficacy and Safety Evaluation of the New Association on Fixed Dose of Olmesartan + Chlorthalidone, Produced by EMS S.A,in Arterial Hypertension Control

Status: Not yet recruiting, Estimated PCD: 2026-06-01

Clinical trial

Efficacy and Safety Evaluation of the New Association on Fixed Dose of Olmesartan Medoxomil + Chlorthalidone (40mg + 12.5mg and 40mg + 25mg) Compared With BENICAR HCT® in Hypertension Control

Status: Not yet recruiting, Estimated PCD: 2025-06-01

Document

DailyMed Label: Benicar Hct

Organization

Physicians Total Care, Inc.

Organization

Cosette Pharmaceuticals, Inc.